Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 186908, 16 pages
http://dx.doi.org/10.1155/2015/186908
Review Article

Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury

1Medical College of Henan University, Kaifeng, Henan 475004, China
2Department of Neurology, Institute of Neurological Disorders, The First Affiliated Hospital of Henan University, Kaifeng 475001, China

Received 17 October 2014; Revised 10 December 2014; Accepted 10 December 2014

Academic Editor: Guangdong Yang

Copyright © 2015 Dongdong Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. K. Eltzschig and T. Eckle, “Ischemia and reperfusion—from mechanism to translation,” Nature Medicine, vol. 17, no. 11, pp. 1391–1401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Duehrkop and R. Rieben, “Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition,” Biochemical Pharmacology, vol. 88, no. 1, pp. 12–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. R. B. Jennings, “Historical perspective on the pathology of myocardial ischemia/reperfusion injury,” Circulation Research, vol. 113, no. 4, pp. 428–438, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Hausenloy and D. M. Yellon, “The therapeutic potential of ischemic conditioning: an update,” Nature Reviews Cardiology, vol. 8, no. 11, pp. 619–629, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Heusch, P. Libby, B. Gersh et al., “Cardiovascular remodelling in coronary artery disease and heart failure,” The Lancet, vol. 383, no. 9932, pp. 1933–1943, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Andreadou, E. K. Iliodromitis, T. Rassaf, R. Schulz, A. Papapetropoulos, and P. Ferdinandy, “The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning,” British Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar
  7. G. K. Kolluru, X. Shen, S. C. Bir, and C. G. Kevil, “Hydrogen sulfide chemical biology: pathophysiological roles and detection,” Nitric Oxide: Biology and Chemistry, vol. 35, pp. 5–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Li and J. R. Lancaster Jr., “Chemical foundations of hydrogen sulfide biology,” Nitric Oxide—Biology and Chemistry, vol. 35, pp. 21–34, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Kimura, “The physiological role of hydrogen sulfide and beyond,” Nitric Oxide - Biology and Chemistry, vol. 41, pp. 4–10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Stein and S. M. Bailey, “Redox biology of hydrogen sulfide: implications for physiology, pathophysiology, and pharmacology,” Redox Biology, vol. 1, no. 1, pp. 32–39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Papapetropoulos, A. Pyriochoua, Z. Altaany et al., “Hydrogen sulfide is an endogenous stimulator of angiogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 51, pp. 21972–21977, 2009. View at Publisher · View at Google Scholar
  12. G. Yang, L. Wu, B. Jiang et al., “H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine γ-lyase,” Science, vol. 322, no. 5901, pp. 587–590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Xue, D.-D. Hao, J.-P. Sun et al., “Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetes,” Antioxidants and Redox Signaling, vol. 19, no. 1, pp. 5–23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. E. M. Bos, R. Wang, P. M. Snijder et al., “Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress,” Journal of the American Society of Nephrology, vol. 24, no. 5, pp. 759–770, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. W. Calvert, M. Elston, C. K. Nicholson et al., “Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice,” Circulation, vol. 122, no. 1, pp. 11–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Fu, X. Liu, B. Geng, L. Fang, and C. Tang, “Hydrogen sulfide protects rat lung from ischemia-reperfusion injury,” Life Sciences, vol. 82, no. 23-24, pp. 1196–1202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Wang, Y. Ma, Z. Li et al., “The role of AKT1 and autophagy in the protective effect of hydrogen sulphide against hepatic ischemia/reperfusion injury in mice,” Autophagy, vol. 8, no. 6, pp. 954–962, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Yin, C. Tu, J. Zhao et al., “Exogenous hydrogen sulfide protects against global cerebral ischemia/reperfusion injury via its anti-oxidative, anti-inflammatory and anti-apoptotic effects in rats,” Brain Research, vol. 1491, pp. 188–196, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. L. lo Faro, B. Fox, J. L. Whatmore et al., “Hydrogen sulfide and nitric oxide interactions in inflammation,” Nitric Oxide, vol. 41, pp. 38–47, 2014. View at Google Scholar
  20. J. P. Collman, S. Ghosh, A. Dey, and R. A. Decréau, “Using a functional enzyme model to understand the chemistry behind hydrogen sulfide induced hibernation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 52, pp. 22090–22095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. B. B. Ríos-González, E. M. Román-Morales, R. Pietri, and J. López-Garriga, “Hydrogen sulfide activation in hemeproteins: the sulfheme scenario,” Journal of Inorganic Biochemistry, vol. 133, pp. 78–86, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Pietri, E. Román-Morales, and J. López-Garriga, “Hydrogen sulfide and hemeproteins: knowledge and mysteries,” Antioxidants and Redox Signaling, vol. 15, no. 2, pp. 393–404, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Hourihan, J. G. Kenna, and J. D. Hayes, “The gasotransmitter hydrogen sulfide induces Nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between Cys-226 and Cys-613,” Antioxidants and Redox Signaling, vol. 19, no. 5, pp. 465–481, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Jiang, G. Tang, K. Cao, L. Wu, and R. Wang, “Molecular mechanism for H2S-induced activation of KATP channels,” Antioxidants and Redox Signaling, vol. 12, no. 10, pp. 1167–1178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S.-N. Ge, M.-M. Zhao, D.-D. Wu et al., “Hydrogen sulfide targets EGFR Cys797/Cys798 residues to induce Na+/K+-ATPase endocytosis and inhibition in renal tubular epithelial cells and increase sodium excretion in chronic salt-loaded rats,” Antioxidants & Redox Signaling, vol. 21, no. 15, pp. 2061–2082, 2014. View at Publisher · View at Google Scholar
  26. B.-B. Tao, S.-Y. Liu, C.-C. Zhang et al., “VEGFR2 functions as an H2S-targeting receptor protein kinase with its novel Cys1045-Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells,” Antioxidants and Redox Signaling, vol. 19, no. 5, pp. 448–464, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. D. J. Polhemus and D. J. Lefer, “Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease,” Circulation Research, vol. 114, no. 4, pp. 730–737, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Shibuya, Y. Mikami, Y. Kimura, N. Nagahara, and H. Kimura, “Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide,” Journal of Biochemistry, vol. 146, no. 5, pp. 623–626, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Shibuya, S. Koike, M. Tanaka et al., “A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells,” Nature Communications, vol. 4, article 1366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Kimura, “Production and physiological effects of hydrogen sulfide,” Antioxidants and Redox Signaling, vol. 20, no. 5, pp. 783–793, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. G. A. Benavides, G. L. Squadrito, R. W. Mills et al., “Hydrogen sulfide mediates the vasoactivity of garlic,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 46, pp. 17977–17982, 2007. View at Publisher · View at Google Scholar
  32. B. L. Predmore, K. Kondo, S. Bhushan et al., “The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 11, pp. H2410–H2418, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. P. M. Snijder, A. S. Frenay, R. A. de Boer et al., “Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates Angiotensin II-induced hypertensive heart disease in rats,” British Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar
  34. T. Imai, Y. Kosuge, K. Endo-Umeda et al., “Protective effect of S-allyl-l-cysteine against endoplasmic reticulum stress-induced neuronal death is mediated by inhibition of calpain,” Amino Acids, vol. 46, no. 2, pp. 385–393, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Zhao, T. D. Biggs, and M. Xian, “Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications,” Chemical Communications (Cambridge), vol. 50, no. 80, pp. 11788–11805, 2014. View at Publisher · View at Google Scholar
  36. P. M. Snijder, R. A. de Boer, E. M. Bos et al., “Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolism,” PLoS ONE, vol. 8, no. 5, Article ID e63291, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. O. Kabil and R. Banerjee, “Redox biochemistry of hydrogen sulfide,” The Journal of Biological Chemistry, vol. 285, no. 29, pp. 21903–21907, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. T. M. Hildebrandt and M. K. Grieshaber, “Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria,” FEBS Journal, vol. 275, no. 13, pp. 3352–3361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. G.-J. Lee, S. K. Kim, S. W. Kang et al., “Real time measurement of myocardial oxygen dynamics during cardiac ischemia-reperfusion of rats,” Analyst, vol. 137, no. 22, pp. 5312–5319, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Fauconnier, A. C. Meli, J. Thireau et al., “Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 32, pp. 13258–13263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Nastos, K. Kalimeris, N. Papoutsidakis et al., “Global consequences of liver ischemia/reperfusion injury,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 906965, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Zhai, H. Petrowsky, J. C. Hong, R. W. Busuttil, and J. W. Kupiec-Weglinski, “Ischaemia-reperfusion injury in liver transplantation—from bench to bedside,” Nature Reviews Gastroenterology & Hepatology, vol. 10, no. 2, pp. 79–89, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Cure, M. Cumhur Cure, L. Tumkaya et al., “Adalimumab ameliorates abdominal aorta cross clamping which induced liver injury in rats,” BioMed Research International, vol. 2014, Article ID 907915, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Elias-Miró, M. B. Jiménez-Castro, J. Rodés, and C. Peralta, “Current knowledge on oxidative stress in hepatic ischemia/reperfusion,” Free Radical Research, vol. 47, no. 8, pp. 555–568, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Mukhopadhyay, B. Horváth, Z. Zsengeller et al., “Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemiareperfusion: therapeutic potential of mitochondrially targeted antioxidants,” Free Radical Biology and Medicine, vol. 53, no. 5, pp. 1123–1138, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Kang, M. Zhao, H. Jiang, G. Tan, S. Pan, and X. Sun, “Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats,” Liver Transplantation, vol. 15, no. 10, pp. 1306–1314, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. G. M. Chertow, E. Burdick, M. Honour, J. V. Bonventre, and D. W. Bates, “Acute kidney injury, mortality, length of stay, and costs in hospitalized patients,” Journal of the American Society of Nephrology, vol. 16, no. 11, pp. 3365–3370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Song, F. Wang, Q. Li et al., “Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy,” Kidney International, vol. 85, no. 6, pp. 1318–1329, 2014. View at Publisher · View at Google Scholar
  49. I. Mühlberger, P. Perco, R. Fechete, B. Mayer, and R. Oberbauer, “Biomarkers in renal transplantation ischemia reperfusion injury,” Transplantation, vol. 88, no. 3S, pp. S14–S19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Bełtowski, “Hypoxia in the renal medulla: implications for hydrogen sulfide signaling,” Journal of Pharmacology and Experimental Therapeutics, vol. 334, no. 2, pp. 358–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Han, G. W. He, and Z. W. Chen, “Protective effect and mechanism of total flavones from Rhododendron simsii planch on endothelium-dependent dilatation and hyperpolarization in cerebral ischemia-reperfusion and correlation to hydrogen sulphide release in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 904019, 11 pages, 2014. View at Publisher · View at Google Scholar
  52. X.-M. Chen, H.-S. Chen, M.-J. Xu, and J.-G. Shen, “Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury,” Acta Pharmacologica Sinica, vol. 34, no. 1, pp. 67–77, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Pan, A.-A. Konstas, B. Bateman, G. A. Ortolano, and J. Pile-Spellman, “Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies,” Neuroradiology, vol. 49, no. 2, pp. 93–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Liu, Y. Sun, Z. Gu, N. Shi, T. Zhang, and X. Sun, “Mitophagy in ischaemia/reperfusion induced cerebral injury,” Neurochemical Research, vol. 38, no. 7, pp. 1295–1300, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Wang, J. Jia, G. Ao et al., “Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia,” Journal of Neurochemistry, vol. 129, no. 5, pp. 827–838, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Jang, M. Y. Oh, Y. J. Kim et al., “Hydrogen sulfide treatment induces angiogenesis after cerebral ischemia,” Journal of Neuroscience Research, vol. 92, no. 11, pp. 1520–1528, 2014. View at Publisher · View at Google Scholar
  57. S. Gheibi, N. Aboutaleb, M. Khaksari et al., “Hydrogen sulfide protects the brain against ischemic reperfusion injury in a transient model of focal cerebral ischemia,” Journal of Molecular Neuroscience, vol. 54, no. 2, pp. 264–270, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. X. Lin, S. Yu, Y. Chen, J. Wu, J. Zhao, and Y. Zhao, “Neuroprotective effects of diallyl sulfide against transient focal cerebral ischemia via anti-apoptosis in rats,” Neurological Research, vol. 34, no. 1, pp. 32–37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Ren, A. Du, D. Li, J. Sui, W. G. Mayhan, and H. Zhao, “Dynamic change of hydrogen sulfide during global cerebral ischemia-reperfusion and its effect in rats,” Brain Research, vol. 1345, pp. 197–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Bhattacharyya, R. Chattopadhyay, S. Mitra, and S. E. Crowe, “Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases,” Physiological Reviews, vol. 94, no. 2, pp. 329–354, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. X. Gan, G. Su, W. Zhao, P. Huang, G. Luo, and Z. Hei, “The mechanism of sevoflurane preconditioning-induced protections against small intestinal ischemia reperfusion injury is independent of mast cell in rats,” Mediators of Inflammation, vol. 2013, Article ID 378703, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Kim, S. W. Park, V. D. D'Agati, and H. T. Lee, “Isoflurane post-conditioning protects against intestinal ischemia-reperfusion injury and multiorgan dysfunction via transforming growth factor-β1 generation,” Annals of Surgery, vol. 255, no. 3, pp. 492–503, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Liu, X.-B. Bai, S. Shi, and Y.-X. Cao, “Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats,” Journal of Pharmacy and Pharmacology, vol. 61, no. 2, pp. 207–212, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. M. C. L. Wu, F. H. Brennan, J. P. L. Lynch et al., “The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 23, pp. 9439–9444, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. P. W. Henderson, A. L. Weinstein, A. M. Sohn, N. Jimenez, D. D. Krijgh, and J. A. Spector, “Hydrogen sulfide attenuates intestinal ischemia-reperfusion injury when delivered in the post-ischemic period,” Journal of Gastroenterology and Hepatology, vol. 25, no. 10, pp. 1642–1647, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Guo, F. Liang, W. S. Masood, and X. Yan, “Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 s-sulfhydration, MAPK dependent anti-apoptosis and NF-κB dependent anti-inflammation pathway,” European Journal of Pharmacology, vol. 725, no. 1, pp. 70–78, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. Li, J.-F. Zhang, Y.-M. Zhang, and X.-B. Ma, “The protective effect of genistein postconditioning on hypoxia/ reoxygenation-induced injury in human gastric epithelial cells,” Acta Pharmacologica Sinica, vol. 30, no. 5, pp. 576–581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Cui, L. Liu, J. Zou et al., “Protective effect of endogenous hydrogen sulfide against oxidative stress in gastric ischemia-reperfusion injury,” Experimental and Therapeutic Medicine, vol. 5, no. 3, pp. 689–694, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. S. A. Mard, N. Neisi, G. Solgi, M. Hassanpour, M. Darbor, and M. Maleki, “Gastroprotective effect of NaHS against mucosal lesions induced by ischemia-reperfusion injury in rat,” Digestive Diseases and Sciences, vol. 57, no. 6, pp. 1496–1503, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. C. J. Ball, A. J. Reiffel, S. Chintalapani, M. Kim, J. A. Spector, and M. R. King, “Hydrogen sulfide reduces neutrophil recruitment in hind-limb ischemia-reperfusion injury in an l-selectin and ADAM-17-dependent manner,” Plastic and Reconstructive Surgery, vol. 131, no. 3, pp. 487–497, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. P. W. Henderson, S. P. Singh, A. L. Weinstein et al., “Therapeutic metabolic inhibition: hydrogen sulfide significantly mitigates skeletal muscle ischemia reperfusion injury in vitro and in vivo,” Plastic and Reconstructive Surgery, vol. 126, no. 6, pp. 1890–1898, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. F. Beyersdorf, “The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage,” Cardiovascular Research, vol. 83, no. 2, pp. 262–268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. P. W. Henderson, N. Jimenez, J. Ruffino et al., “Therapeutic delivery of hydrogen sulfide for salvage of ischemic skeletal muscle after the onset of critical ischemia,” Journal of Vascular Surgery, vol. 53, no. 3, pp. 785–791, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. W. Chen, G. Zheng, S. Yang et al., “CYP2J2 and EETs protect against oxidative stress and apoptosis in vivo and in vitro following lung ischemia/reperfusion,” Cellular Physiology and Biochemistry, vol. 33, no. 6, pp. 1663–1680, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee, “Ischemia-reperfusion-induced lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 4, pp. 490–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. W. A. den Hengst, J. F. Gielis, J. Y. Lin, P. E. van Schil, L. J. de Windt, and A. L. Moens, “Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 299, no. 5, pp. H1283–H1299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Zhang, J.-S. Wang, Z.-K. Zheng et al., “Participation of autophagy in lung ischemia-reperfusion injury in vivo,” Journal of Surgical Research, vol. 182, no. 2, pp. E79–E87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. J. M. Dodd-o, M. L. Hristopoulos, L. E. Welsh-Servinsky, C. G. Tankersley, and D. B. Pearse, “Strain-specific differences in sensitivity to ischemia-reperfusion lung injury in mice,” Journal of Applied Physiology, vol. 100, no. 5, pp. 1590–1595, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. J.-H. Cho, X. Mu, S. W. Wang, and W. H. Klein, “Retinal ganglion cell death and optic nerve degeneration by genetic ablation in adult mice,” Experimental Eye Research, vol. 88, no. 3, pp. 542–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. B.-J. Kim, T. A. Braun, R. J. Wordinger, and A. F. Clark, “Progressive morphological changes and impaired retinal function associated with temporal regulation of gene expression after retinal ischemia/reperfusion injury in mice,” Molecular Neurodegeneration, vol. 8, no. 1, article 21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Andreeva, M. Zhang, W. Fan et al., “Time-dependent gene profiling indicates the presence of different phases for ischemia/reperfusion injury in retina,” Ophthalmology and Eye Diseases, vol. 6, pp. 43–54, 2014. View at Publisher · View at Google Scholar
  82. M.-H. Sun, J.-H. S. Pang, S.-L. Chen et al., “Retinal protection from acute glaucoma-induced ischemia-reperfusion injury through pharmacologic induction of heme oxygenase-1,” Investigative Ophthalmology & Visual Science, vol. 51, no. 9, pp. 4798–4808, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. N. N. Osborne, R. J. Casson, J. P. M. Wood, G. Chidlow, M. Graham, and J. Melena, “Retinal ischemia: mechanisms of damage and potential therapeutic strategies,” Progress in Retinal and Eye Research, vol. 23, no. 1, pp. 91–147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Biermann, W. A. Lagrèze, N. Schallner, C. I. Schwer, and U. Goebel, “Inhalative preconditioning with hydrogen sulfide attenuated apoptosis after retinal ischemia/reperfusion injury,” Molecular Vision, vol. 17, pp. 1275–1286, 2011. View at Google Scholar · View at Scopus
  85. N. N. Osborne, D. Ji, A. S. A. Majid, R. J. Fawcett, A. Sparatore, and P. Del Soldato, “ACS67, a hydrogen sulfide-releasing derivative of latanoprost acid, attenuates retinal ischemia and oxidative stress to RGC-5 cells in culture,” Investigative Ophthalmology and Visual Science, vol. 51, no. 1, pp. 284–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. L. Li, M. Whiteman, Y. Y. Guan et al., “Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide,” Circulation, vol. 117, no. 18, pp. 2351–2360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. Z.-W. Lee, X.-Y. Teo, E. Y.-W. Tay et al., “Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance,” British Journal of Pharmacology, vol. 171, no. 18, pp. 4322–4336, 2014. View at Publisher · View at Google Scholar
  88. C. N. Wang, Y. J. Liu, G. L. Duan et al., “CBS and CSE are critical for maintenance of mitochondrial function and glucocorticoid production in adrenal cortex,” Antioxidants & Redox Signaling, vol. 21, no. 16, pp. 2192–2207, 2014. View at Google Scholar
  89. N. Ning, J. Zhu, Y. Du, X. Gao, C. Liu, and J. Li, “Dysregulation of hydrogen sulphide metabolism impairs oviductal transport of embryos,” Nature Communications, vol. 5, p. 4107, 2014. View at Publisher · View at Google Scholar
  90. H. Robinson and S. Wray, “A new slow releasing, H2S generating compound, GYY4137 relaxes spontaneous and oxytocin-stimulated contractions of human and rat pregnant myometrium,” PLoS ONE, vol. 7, no. 9, Article ID e46278, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. E. Grambow, F. Mueller-Graf, E. Delyagina, M. Frank, A. Kuhla, and B. Vollmar, “Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice,” Platelets, vol. 25, no. 3, pp. 166–174, 2014. View at Publisher · View at Google Scholar
  92. J. Jia, Y. Xiao, W. Wang et al., “Differential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress,” Neurochemistry International, vol. 62, no. 8, pp. 1072–1078, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. C. Köhn, J. Schleifenbaum, I. A. Szijártó et al., “Differential effects of cystathionine-γ-lyase-dependent vasodilatory H2S in periadventitial vasoregulation of rat and mouse aortas,” PLoS ONE, vol. 7, no. 8, Article ID e41951, 2012. View at Publisher · View at Google Scholar · View at Scopus
  94. X. Zhou, Y. Cao, G. Ao et al., “CaMKKβ-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation,” Antioxidants & Redox Signaling, vol. 21, no. 12, pp. 1741–1758, 2014. View at Publisher · View at Google Scholar
  95. B. Szczesny, K. Módis, K. Yanagi et al., “AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro,” Nitric Oxide: Biology and Chemistry, vol. 41, pp. 120–130, 2014. View at Publisher · View at Google Scholar · View at Scopus
  96. J. C. Foster, C. R. Powell, S. C. Radzinski, and J. B. Matson, “S-aroylthiooximes: a facile route to hydrogen sulfide releasing compounds with structure-dependent release kinetics,” Organic Letters, vol. 16, no. 6, pp. 1558–1561, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. J. Kan, W. Guo, C. Huang, G. Bao, Y. Zhu, and Y. Z. Zhu, “S-propargyl-cysteine, a novel water-soluble modulator of endogenous hydrogen sulfide, promotes angiogenesis through activation of signal transducer and activator of transcription 3,” Antioxidants & Redox Signaling, vol. 20, no. 15, pp. 2303–2316, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. K. Ma, Y. Liu, Q. Zhu et al., “H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S?” PLoS ONE, vol. 6, no. 6, Article ID e20525, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. Q. Wang, X.-L. Wang, H.-R. Liu, P. Rose, and Y.-Z. Zhu, “Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H2S production,” Antioxidants and Redox Signaling, vol. 12, no. 10, pp. 1155–1165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. L.-L. Pan, X.-H. Liu, Q.-H. Gong, and Y.-Z. Zhu, “S-propargyl-cysteine (SPRC) attenuated lipopolysaccharide-induced inflammatory response in H9c2 cells involved in a hydrogen sulfide-dependent mechanism,” Amino Acids, vol. 41, no. 1, pp. 205–215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. K. Kondo, S. Bhushan, A. L. King et al., “H2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase,” Circulation, vol. 127, no. 10, pp. 1116–1127, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. F. Liu, D.-D. Chen, X. Sun et al., “Hydrogen sulfide improves wound healing via restoration of endothelial progenitor cell functions and activation of angiopoietin-1 in type 2 diabetes,” Diabetes, vol. 63, no. 5, pp. 1763–1778, 2014. View at Publisher · View at Google Scholar · View at Scopus
  103. A. Martelli, L. Testai, V. Citi et al., “Arylthioamides as H2S donors: l-cysteine-activated releasing properties and vascular effects in vitro and in vivo,” ACS Medicinal Chemistry Letters, vol. 4, no. 10, pp. 904–908, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. Y. Zhao, H. Wang, and M. Xian, “Cysteine-activated hydrogen sulfide (H2S) donors,” Journal of the American Chemical Society, vol. 133, no. 1, pp. 15–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. D. Giustarini, A. Milzani, I. Dalle-Donne, D. Tsikas, and R. Rossi, “N-acetylcysteine ethyl ester (NACET): a novel lipophilic cell-permeable cysteine derivative with an unusual pharmacokinetic feature and remarkable antioxidant potential,” Biochemical Pharmacology, vol. 84, no. 11, pp. 1522–1533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. A. Martelli, L. Testai, V. Citi et al., “Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player?” Vascular Pharmacology, vol. 60, no. 1, pp. 32–41, 2014. View at Publisher · View at Google Scholar · View at Scopus
  107. E. Ekundi-Valentim, K. T. Santos, E. A. Camargo et al., “Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat: research paper,” British Journal of Pharmacology, vol. 159, no. 7, pp. 1463–1474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. J. V. R. Medeiros, V. H. Bezerra, A. S. Gomes et al., “Hydrogen sulfide prevents ethanol-induced gastric damage in mice: role of ATP-sensitive potassium channels and capsaicin-sensitive primary afferent neurons,” Journal of Pharmacology and Experimental Therapeutics, vol. 330, no. 3, pp. 764–770, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. Z. Zhou, M. Von Wantoch Rekowski, C. Coletta et al., “Thioglycine and l-thiovaline: biologically active H2S-donors,” Bioorganic and Medicinal Chemistry, vol. 20, no. 8, pp. 2675–2678, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. Y. Zhao, S. Bhushan, C. Yang et al., “Controllable hydrogen sulfide donors and their activity against myocardial ischemia-reperfusion injury,” ACS Chemical Biology, vol. 8, no. 6, pp. 1283–1290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  111. N. Fukushima, N. Ieda, K. Sasakura et al., “Synthesis of a photocontrollable hydrogen sulfide donor using ketoprofenate photocages,” Chemical Communications, vol. 50, no. 5, pp. 587–589, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. V. Citi, A. Martelli, L. Testai, A. Marino, M. Breschi, and V. Calderone, “Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of Brassicaceae?” Planta Medica, vol. 80, no. 8-9, pp. 610–613, 2014. View at Publisher · View at Google Scholar
  113. U. Hasegawa and A. J. van der Vlies, “Design and synthesis of polymeric hydrogen sulfide donors,” Bioconjugate Chemistry, vol. 25, no. 7, pp. 1290–1300, 2014. View at Publisher · View at Google Scholar
  114. E. Marutani, S. Kosugi, K. Tokuda et al., “A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death,” The Journal of Biological Chemistry, vol. 287, no. 38, pp. 32124–32135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. N. N. Osborne, D. Ji, A. S. A. Majid, P. Del Soldata, and A. Sparatore, “Glutamate oxidative injury to RGC-5 cells in culture is necrostatin sensitive and blunted by a hydrogen sulfide (H2S)-releasing derivative of aspirin (ACS14),” Neurochemistry International, vol. 60, no. 4, pp. 365–378, 2012. View at Publisher · View at Google Scholar · View at Scopus
  116. C. H. Switzer, R. Y.-S. Cheng, L. A. Ridnour et al., “Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer,” Cancer Research, vol. 72, no. 9, pp. 2394–2404, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. J. S. Isenberg, Y. Jia, L. Field et al., “Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid,” British Journal of Pharmacology, vol. 151, no. 1, pp. 63–72, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. M. Lee, V. Tazzari, D. Giustarini et al., “Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease,” Journal of Biological Chemistry, vol. 285, no. 23, pp. 17318–17328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. X.-Q. Tang, R.-Q. Chen, L. Dong et al., “Role of paraoxonase-1 in the protection of hydrogen sulfide-donating sildenafil (ACS6) against homocysteine-induced neurotoxicity,” Journal of Molecular Neuroscience, vol. 50, no. 1, pp. 70–77, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Muzaffar, J. Y. Jeremy, A. Sparatore, P. Del Soldato, G. D. Angelini, and N. Shukla, “H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91 phox expression in arterial endothelial cells: Role of protein kinases A and G,” British Journal of Pharmacology, vol. 155, no. 7, pp. 984–994, 2008. View at Publisher · View at Google Scholar · View at Scopus
  121. Q. Huang, A. Sparatore, P. Del Soldato, L. Wu, K. Desai, and R. Nagaraj, “Hydrogen sulfide releasing aspirin, ACS14, attenuates high glucose-induced increased methylglyoxal and oxidative stress in cultured vascular smooth muscle cells,” PLoS ONE, vol. 9, no. 6, Article ID e97315, 2014. View at Publisher · View at Google Scholar
  122. H. Zhang, C. Guo, A. Zhang et al., “Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice,” European Journal of Pharmacology, vol. 697, no. 1–3, pp. 106–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  123. J. Pircher, F. Fochler, T. Czermak et al., “Hydrogen sulfide-releasing aspirin derivative acs14 exerts strong antithrombotic effects in vitro and in vivo,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 12, pp. 2884–2891, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. G. Rossoni, B. Manfredi, V. Tazzari et al., “Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats,” European Journal of Pharmacology, vol. 648, no. 1–3, pp. 139–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  125. D. Giustarini, P. Del Soldato, A. Sparatore, and R. Rossi, “Modulation of thiol homeostasis induced by H2S-releasing aspirin,” Free Radical Biology and Medicine, vol. 48, no. 9, pp. 1263–1272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  126. S. E. Bass, P. Sienkiewicz, C. J. MacDonald et al., “Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells,” Clinical Cancer Research, vol. 15, no. 6, pp. 1964–1972, 2009. View at Publisher · View at Google Scholar · View at Scopus
  127. J. Frantzias, J. G. Logan, P. Mollat et al., “Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo,” British Journal of Pharmacology, vol. 165, no. 6, pp. 1914–1925, 2012. View at Publisher · View at Google Scholar · View at Scopus
  128. M. Bhatia, J. N. Sidhapuriwala, A. Sparatore, and P. K. Moore, “Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury,” Shock, vol. 29, no. 1, pp. 84–88, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. A. Tesei, G. Brigliadori, S. Carloni et al., “Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity,” Journal of Cellular Physiology, vol. 227, no. 10, pp. 3389–3396, 2012. View at Publisher · View at Google Scholar · View at Scopus
  130. E. Perrino, C. Uliva, C. Lanzi, P. D. Soldato, E. Masini, and A. Sparatore, “New prostaglandin derivative for glaucoma treatment,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 6, pp. 1639–1642, 2009. View at Publisher · View at Google Scholar · View at Scopus
  131. B. L. Predmore, D. J. Lefer, and G. Gojon, “Hydrogen sulfide in biochemistry and medicine,” Antioxidants & Redox Signaling, vol. 17, no. 1, pp. 119–140, 2012. View at Publisher · View at Google Scholar · View at Scopus
  132. L. Xie, L.-F. Hu, X. Q. Teo et al., “Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model,” PLoS ONE, vol. 8, no. 4, Article ID e60200, 2013. View at Publisher · View at Google Scholar · View at Scopus
  133. C. Szabõ, “Hydrogen sulphide and its therapeutic potential,” Nature Reviews Drug Discovery, vol. 6, no. 11, pp. 917–935, 2007. View at Publisher · View at Google Scholar · View at Scopus
  134. J. L. Wallace, G. Caliendo, V. Santagada, G. Cirino, and S. Fiorucci, “Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat,” Gastroenterology, vol. 132, no. 1, pp. 261–271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  135. J. L. Wallace, “Hydrogen sulfide-releasing anti-inflammatory drugs,” Trends in Pharmacological Sciences, vol. 28, no. 10, pp. 501–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  136. J. L. Wallace, G. Caliendo, V. Santagada, and G. Cirino, “Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346),” British Journal of Pharmacology, vol. 159, no. 6, pp. 1236–1246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  137. W. Elsheikh, R. W. Blackler, K. L. Flannigan, and J. L. Wallace, “Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer,” Nitric Oxide, vol. 41, pp. 131–137, 2014. View at Publisher · View at Google Scholar · View at Scopus
  138. S. Fiorucci, S. Orlandi, A. Mencarelli et al., “Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis,” British Journal of Pharmacology, vol. 150, no. 8, pp. 996–1002, 2007. View at Publisher · View at Google Scholar · View at Scopus
  139. E. Distrutti, L. Sediari, A. Mencarelli et al., “5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity,” Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 1, pp. 447–458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  140. M. Chattopadhyay, R. Kodela, N. Nath, A. Barsegian, D. Boring, and K. Kashfi, “Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo,” Biochemical Pharmacology, vol. 83, no. 6, pp. 723–732, 2012. View at Publisher · View at Google Scholar · View at Scopus
  141. X. Wang, L. Wang, X. Sheng et al., “Design, synthesis and biological evaluation of hydrogen sulfide releasing derivatives of 3-n-butylphthalide as potential antiplatelet and antithrombotic agents,” Organic & Biomolecular Chemistry, vol. 12, no. 31, pp. 5995–6004, 2014. View at Publisher · View at Google Scholar
  142. A. Martelli, L. Testai, A. Marino, M. C. Breschi, F. da Settimo, and V. Calderone, “Hydrogen sulphide: biopharmacological roles in the cardiovascular system and pharmaceutical perspectives,” Current Medicinal Chemistry, vol. 19, no. 20, pp. 3325–3336, 2012. View at Publisher · View at Google Scholar · View at Scopus
  143. M. Chattopadhyay, R. Kodela, K. R. Olson, and K. Kashfi, “NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model,” Biochemical and Biophysical Research Communications, vol. 419, no. 3, pp. 523–528, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. M. Lee, E. Mcgeer, R. Kodela, K. Kashfi, and P. L. Mcgeer, “NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders,” Glia, vol. 61, no. 10, pp. 1724–1734, 2013. View at Publisher · View at Google Scholar · View at Scopus
  145. R. Kodela, M. Chattopadhyay, and K. Kashfi, “Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential,” MedChemComm, vol. 4, no. 11, pp. 1472–1481, 2013. View at Publisher · View at Google Scholar · View at Scopus
  146. G. Rossoni, A. Sparatore, V. Tazzari, B. Manfredi, P. D. Soldato, and F. Berti, “The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart,” British Journal of Pharmacology, vol. 153, no. 1, pp. 100–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  147. M. Bucci, V. Vellecco, A. Cantalupo et al., “Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition,” Cardiovascular Research, vol. 102, no. 1, pp. 138–147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  148. K. Issa, A. Kimmoun, S. Collin et al., “Compared effects of inhibition and exogenous administration of hydrogen sulphide in ischaemia-reperfusion injury,” Critical Care, vol. 17, article R129, 2013. View at Publisher · View at Google Scholar · View at Scopus
  149. A. Sivarajah, M. Collino, M. Yasin et al., “Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial l/R,” Shock, vol. 31, no. 3, pp. 267–274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  150. M. G. Alves, A. F. Soares, R. A. Carvalho, and P. J. Oliveira, “Sodium hydrosulfide improves the protective potential of the cardioplegic histidine buffer solution,” European Journal of Pharmacology, vol. 654, no. 1, pp. 60–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  151. Y. Ji, Q.-F. Pang, G. Xu, L. Wang, J.-K. Wang, and Y.-M. Zeng, “Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury,” European Journal of Pharmacology, vol. 587, no. 1–3, pp. 1–7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  152. W.-H. Sun, F. Liu, Y. Chen, and Y.-C. Zhu, “Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion,” Biochemical and Biophysical Research Communications, vol. 421, no. 2, pp. 164–169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  153. H.-F. Luan, Z.-B. Zhao, Q.-H. Zhao, P. Zhu, M.-Y. Xiu, and Y. Ji, “Hydrogen sulfide postconditioning protects isolated rat hearts against ischemia and reperfusion injury mediated by the JAK2/STAT3 survival pathway,” Brazilian Journal of Medical and Biological Research, vol. 45, no. 10, pp. 898–905, 2012. View at Publisher · View at Google Scholar · View at Scopus
  154. M. Bliksøen, M.-L. Kaljusto, J. Vaage, and K.-O. Stensløkken, “Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart,” European Journal of Cardio-thoracic Surgery, vol. 34, no. 2, pp. 344–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  155. D. J. Elsey, R. C. Fowkes, and G. F. Baxter, “L-cysteine stimulates hydrogen sulfide synthesis in myocardium associated with attenuation of ischemia-reperfusion injury,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 15, no. 1, pp. 53–59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  156. Y. Gao, X. Yao, Y. Zhang et al., “The protective role of hydrogen sulfide in myocardial ischemia-reperfusion-induced injury in diabetic rats,” International Journal of Cardiology, vol. 152, no. 2, pp. 177–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  157. J. S. Bian, C. Y. Qian, T. T. Pan et al., “Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes,” Journal of Pharmacology and Experimental Therapeutics, vol. 316, no. 2, pp. 670–678, 2006. View at Publisher · View at Google Scholar · View at Scopus
  158. Y. Hu, X. Chen, T.-T. Pan et al., “Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways,” Pflugers Archiv European Journal of Physiology, vol. 455, no. 4, pp. 607–616, 2008. View at Publisher · View at Google Scholar · View at Scopus
  159. L.-F. Hu, T.-T. Pan, K. L. Neo, Q. C. Yong, and J.-S. Bian, “Cyclooxygenase-2 mediates the delayed cardioprotection induced by hydrogen sulfide preconditioning in isolated rat cardiomyocytes,” Pflugers Archiv European Journal of Physiology, vol. 455, no. 6, pp. 971–978, 2008. View at Publisher · View at Google Scholar · View at Scopus
  160. N. R. Sodha, R. T. Clements, J. Feng et al., “Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury,” Journal of Thoracic and Cardiovascular Surgery, vol. 138, no. 4, pp. 977–984, 2009. View at Publisher · View at Google Scholar · View at Scopus
  161. N. R. Sodha, R. T. Clements, J. Feng et al., “The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury,” European Journal of Cardio-Thoracic Surgery, vol. 33, no. 5, pp. 906–913, 2008. View at Publisher · View at Google Scholar · View at Scopus
  162. D. Johansen, K. Ytrehus, and G. F. Baxter, “Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury. Evidence for a role of KATP channels,” Basic Research in Cardiology, vol. 101, no. 1, pp. 53–60, 2006. View at Publisher · View at Google Scholar · View at Scopus
  163. F. Ganster, M. Burban, M. de la Bourdonnaye et al., “Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats,” Critical Care, vol. 14, no. 5, article R165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  164. L. L. Yao, X. W. Huang, Y. G. Wang, Y. X. Cao, C. C. Zhang, and Y. C. Zhu, “Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3β-dependent opening of mPTP,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 5, pp. H1310–H1319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  165. B. F. Peake, C. K. Nicholson, J. P. Lambert et al., “Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 304, no. 9, pp. H1215–H1224, 2013. View at Publisher · View at Google Scholar · View at Scopus
  166. X. Yao, G. Tan, C. He et al., “Hydrogen sulfide protects cardiomyocytes from myocardial ischemia-reperfusion injury by enhancing phosphorylation of apoptosis repressor with caspase recruitment domain,” The Tohoku Journal of Experimental Medicine, vol. 226, no. 4, pp. 275–285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  167. J. W. Elrod, J. W. Calvert, J. Morrison et al., “Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 39, pp. 15560–15565, 2007. View at Publisher · View at Google Scholar · View at Scopus
  168. S. Toldo, A. Das, E. Mezzaroma et al., “Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice,” Circulation: Cardiovascular Genetics, vol. 7, no. 3, pp. 311–320, 2014. View at Google Scholar
  169. J. W. Calvert, S. Jha, S. Gundewar et al., “Hydrogen sulfide mediates cardioprotection through nrf2 signaling,” Circulation Research, vol. 105, no. 4, pp. 365–374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  170. W.-J. Zhang, Z.-X. Shi, B.-B. Wang, Y.-J. Cui, J.-Z. Guo, and B. Li, “Allitridum mimics effect of ischemic preconditioning by activation of protein kinase C,” Acta Pharmacologica Sinica, vol. 22, no. 2, pp. 132–136, 2001. View at Google Scholar · View at Scopus
  171. Y. Zhou, D. Wang, X. Gao, K. Lew, A. M. Richards, and P. Wang, “mTORC2 phosphorylation of Akt1: a possible mechanism for hydrogen sulfide-induced cardioprotection,” PLoS ONE, vol. 9, no. 6, Article ID e99665, 2014. View at Publisher · View at Google Scholar
  172. A. Sivarajah, M. C. McDonald, and C. Thiemermann, “The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat,” Shock, vol. 26, no. 2, pp. 154–161, 2006. View at Publisher · View at Google Scholar · View at Scopus
  173. B. Kang, J. Hong, J. Xiao et al., “Involvement of miR-1 in the protective effect of hydrogen sulfide against cardiomyocyte apoptosis induced by ischemia/reperfusion,” Molecular Biology Reports, vol. 41, no. 10, pp. 6845–6853, 2014. View at Publisher · View at Google Scholar
  174. S. Minamishima, M. Bougaki, P. Y. Sips et al., “Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice,” Circulation, vol. 120, no. 10, pp. 888–896, 2009. View at Publisher · View at Google Scholar · View at Scopus
  175. Y. Zhuo, P.-F. Chen, A.-Z. Zhang, H. Zhong, C.-Q. Chen, and Y.-Z. Zhu, “Cardioprotective effect of hydrogen sulfide in ischemic reperfusion experimental rats and its influence on expression of survivin gene,” Biological and Pharmaceutical Bulletin, vol. 32, no. 8, pp. 1406–1410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  176. R. M. Osipov, M. P. Robich, J. Feng et al., “Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection,” Journal of Cardiovascular Pharmacology, vol. 54, no. 4, pp. 287–297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  177. Y. Chen, Z. Liu, and X. Xie, “Hydrogen sulphide attenuates renal and cardiac injury after total hepatic ischemia and reperfusion,” Journal of Surgical Research, vol. 164, no. 2, pp. e305–e313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  178. I. H. Shaik, J. M. George, T. J. Thekkumkara, and R. Mehvar, “Protective effects of diallyl sulfide, a garlic constituent, on the warm hepatic ischemia-reperfusion injury in a rat model,” Pharmaceutical Research, vol. 25, no. 10, pp. 2231–2242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  179. S. Jha, J. W. Calvert, M. R. Duranski, A. Ramachandran, and D. J. Lefer, “Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 295, no. 2, pp. H801–H806, 2008. View at Publisher · View at Google Scholar · View at Scopus
  180. E. M. Bos, P. M. Snijder, H. Jekel et al., “Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury,” Transplant International, vol. 25, no. 8, pp. 897–908, 2012. View at Publisher · View at Google Scholar · View at Scopus
  181. P. Cheng, F. Wang, K. Chen et al., “Hydrogen sulfide ameliorates ischemia/reperfusion-induced hepatitis by inhibiting apoptosis and autophagy pathways,” Mediators of Inflammation, vol. 2014, Article ID 935251, 16 pages, 2014. View at Publisher · View at Google Scholar
  182. Q. Zhang, H. Fu, H. Zhang et al., “Hydrogen sulfide preconditioning protects rat liver against ischemia/reperfusion injury by activating Akt-GSK-3β signaling and inhibiting mitochondrial permeability transition,” PLoS ONE, vol. 8, no. 9, Article ID e74422, 2013. View at Publisher · View at Google Scholar · View at Scopus
  183. E. M. Bos, H. G. D. Leuvenink, P. M. Snijder et al., “Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury,” Journal of the American Society of Nephrology, vol. 20, no. 9, pp. 1901–1905, 2009. View at Publisher · View at Google Scholar · View at Scopus
  184. J. P. Hunter, S. A. Hosgood, M. Patel, R. Rose, K. Read, and M. L. Nicholson, “Effects of hydrogen sulphide in an experimental model of renal ischaemia-reperfusion injury,” British Journal of Surgery, vol. 99, no. 12, pp. 1665–1671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  185. S. A. Hosgood and M. L. Nicholson, “Hydrogen sulphide ameliorates ischaemia-reperfusion injury in an experimental model of non-heart-beating donor kidney transplantation,” British Journal of Surgery, vol. 97, no. 2, pp. 202–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  186. P. Tripatara, N. S. A. Patel, V. Brancaleone et al., “Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: an in vivo study,” European Journal of Pharmacology, vol. 606, no. 1–3, pp. 205–209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  187. P. Tripatara, N. S. A. Patel, M. Collino et al., “Generation of endogenous hydrogen sulfide by cystathionine γ-lyase limits renal ischemia/reperfusion injury and dysfunction,” Laboratory Investigation, vol. 88, no. 10, pp. 1038–1048, 2008. View at Publisher · View at Google Scholar · View at Scopus
  188. I. Lobb, J. Zhu, W. Liu, A. Haig, Z. Lan, and A. Sener, “Hydrogen sulfide treatment ameliorates long-term renal dysfunction resulting from prolonged warm renal ischemia-reperfusion injury,” Canadian Urological Association Journal, vol. 8, no. 5-6, pp. E413–E418, 2014. View at Google Scholar
  189. J. X. G. Zhu, M. Kalbfleisch, Y. X. Yang et al., “Detrimental effects of prolonged warm renal ischaemia-reperfusion injury are abrogated by supplemental hydrogen sulphide: an analysis using real-time intravital microscopy and polymerase chain reaction,” BJU International, vol. 110, no. 11, pp. E1218–E1227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  190. F. Simon, A. Scheuerle, M. Gröger et al., “Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury,” Shock, vol. 35, no. 2, pp. 156–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  191. Z. Xu, G. Prathapasinghe, N. Wu, S. Y. Hwang, Y. L. Siow, and O. Karmin, “Ischemia-reperfusion reduces cystathionine-β-synthase-mediated hydrogen sulfide generation in the kidney,” The American Journal of Physiology—Renal Physiology, vol. 297, no. 1, pp. F27–F35, 2009. View at Publisher · View at Google Scholar · View at Scopus